Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 22Dermatologic 8Thoracic 6Other hematologic neoplasm 6Plasma cell 5Head & Neck 5Gastrointestinal 5Gynecologic 4Genitourinary 4CNS 4Breast 3Sarcoma 2Myeloid 2

Conditions

Sarcoma 32Melanoma 10Osteosarcoma 8Neoplasm Metastasis 8Sarcoma, Kaposi 6Leiomyosarcoma 6Histiocytoma, Malignant Fibrous 6Chordoma 6Gliosarcoma 5Colorectal Neoplasms 5Carcinosarcoma 5Carcinoma, Transitional Cell 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sarcoma, Ewing 4Neuroblastoma 4Neoplasms 4Bone Neoplasms 4Rhabdomyosarcoma 3Neurofibrosarcoma 3Lung Neoplasms 3Hemangiosarcoma 3Glioblastoma 3Gastrointestinal Stromal Tumors 3Endometrial Neoplasms 3Desmoid Tumors 3Cholangiocarcinoma 3

Interventions

Cyclophosphamide 58Filgrastim 37Radiotherapy 31Busulfan 28fludarabine phosphate 26Antilymphocyte Serum 25Cyclosporine 24Peripheral Blood Stem Cell Transplantation 23Etoposide 22Methotrexate 20Melphalan 18Mycophenolic Acid 17Cord Blood Stem Cell Transplantation 17Methylprednisolone 16Vincristine 13Cytarabine 13Tacrolimus 12Rituximab 11Whole-Body Irradiation 9Thiotepa 9Prednisone 9Doxorubicin 8Leucovorin 7sargramostim 6aldesleukin 6Granulocyte Colony-Stimulating Factor 6Psychiatric Rehabilitation 5Daunorubicin 5pembrolizumab 4Sirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma × Nivolumab × Sarcoma × Clear all
NCT04730349 2023-03-24

PIVOT IO 020

Bristol-Myers Squibb

Phase 1/2 Terminated
15 enrolled 14 charts
CNSDermatologicLymphoidOther hematologic neoplasmSarcoma

Ependymoma, Glioma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Neoplasms, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Leukemia, B-Cell

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡